文献速递复苏、休克与脓毒症心脑血管急症重症综合管理与镇静镇痛

院外心脏骤停后低温治疗与常温治疗比较

Hypothermia versus Normothermia after Out-of-Hospital Cardiac Arrest.
PubMed 文献 · N Engl J Med · 2021-01-01
一句话结论院外心脏骤停昏迷患者中,33°C目标低温治疗6个月病死率未低于目标常温治疗(50% vs 48%,RR 1.04)。

该开放标签、结局盲法评估的随机对照试验纳入1900例院外心脏骤停后昏迷的成人患者,比较33°C目标低温(随后控速复温)与目标常温(体温≥37.8°C即早期处理发热)。主要终点6个月全因死亡在低温组为50%(465/925),常温组为48%(446/925),RR 1.04(95%CI 0.94–1.14,P=0.37),差异未达统计学显著。6个月改良Rankin量表评分≥4分的比例两组均为55%(RR 1.00,95%CI 0.92–1.09)。预设亚组结果一致。低温组导致血流动力学受损的心律失常更常见(24% vs 17%,P<0.001)。作者认为,院外心脏骤停后昏迷患者中,目标低温未较目标常温降低6个月死亡发生率。

要点

  • 6个月全因死亡:低温组50%(465/925)vs 常温组48%(446/925),RR 1.04(95%CI 0.94–1.14,P=0.37),未达统计学显著。
  • 6个月改良Rankin量表评分≥4分:低温组55%(488/881)vs 常温组55%(479/866),RR 1.00(95%CI 0.92–1.09)。
  • 导致血流动力学受损的心律失常低温组24% vs 常温组17%(P<0.001)。
  • 肺炎、脓毒症、出血及温度管理装置相关皮肤并发症的发生率两组无显著差异。
  • 性别、年龄、初始心律、自主循环恢复时间、入院时是否休克等预设亚组结果一致。

适用人群与场景

  • 纳入:1900例院外心脏骤停后昏迷的成人患者,心脏骤停原因推测为心源性或原因不明。

诊断标准与关键阈值

  • 目标低温:33°C,随后控速复温。
  • 目标常温:早期处理发热,体温≥37.8°C即干预。
  • 功能结局用改良Rankin量表评估,评分≥4分为中度严重残疾或更差。

处置流程与药物剂量

  • 低温组:目标温度33°C,随后进行控速复温。
  • 常温组:目标常温,体温≥37.8°C时早期处理发热。

红旗征与不能漏的情况

  • 导致血流动力学受损的心律失常在低温组更常见(24% vs 17%,P<0.001)。

研究设计与关键结果

  • 研究类型:开放标签、结局盲法评估的随机对照试验,纳入1900例院外心脏骤停后昏迷的成人患者。
  • 主要终点:6个月全因死亡,低温组50%(465/925)vs 常温组48%(446/925),RR 1.04(95%CI 0.94–1.14,P=0.37),未达统计学显著。
  • 次要终点:6个月改良Rankin量表评分≥4分,低温组55%(488/881)vs 常温组55%(479/866),RR 1.00(95%CI 0.92–1.09)。
  • 预设亚组(性别、年龄、初始心律、自主循环恢复时间、入院时是否休克)结果一致。
  • 不良事件:导致血流动力学受损的心律失常低温组24% vs 常温组17%(P<0.001);肺炎、脓毒症、出血及温度管理装置相关皮肤并发症两组无显著差异。

证据类型、等级与局限

  • 证据类型:随机对照试验(TTM2,NCT02908308)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,院外心脏骤停后昏迷患者中,目标低温(33°C)未较目标常温(体温≥37.8°C即处理发热)降低6个月死亡发生率。
  • 低温治疗与导致血流动力学受损的心律失常增加相关(24% vs 17%,P<0.001)。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Targeted temperature management is recommended for patients after cardiac arrest, but the supporting evidence is of low certainty.

METHODS: In an open-label trial with blinded assessment of outcomes, we randomly assigned 1900 adults with coma who had had an out-of-hospital cardiac arrest of presumed cardiac or unknown cause to undergo targeted hypothermia at 33°C, followed by controlled rewarming, or targeted normothermia with early treatment of fever (body temperature, ≥37.8°C). The primary outcome was death from any cause at 6 months. Secondary outcomes included functional outcome at 6 months as assessed with the modified Rankin scale. Prespecified subgroups were defined according to sex, age, initial cardiac rhythm, time to return of spontaneous circulation, and presence or absence of shock on admission. Prespecified adverse events were pneumonia, sepsis, bleeding, arrhythmia resulting in hemodynamic compromise, and skin complications related to the temperature management device.

RESULTS: A total of 1850 patients were evaluated for the primary outcome. At 6 months, 465 of 925 patients (50%) in the hypothermia group had died, as compared with 446 of 925 (48%) in the normothermia group (relative risk with hypothermia, 1.04; 95% confidence interval [CI], 0.94 to 1.14; P = 0.37). Of the 1747 patients in whom the functional outcome was assessed, 488 of 881 (55%) in the hypothermia group had moderately severe disability or worse (modified Rankin scale score ≥4), as compared with 479 of 866 (55%) in the normothermia group (relative risk with hypothermia, 1.00; 95% CI, 0.92 to 1.09). Outcomes were consistent in the prespecified subgroups. Arrhythmia resulting in hemodynamic compromise was more common in the hypothermia group than in the normothermia group (24% vs. 17%, P<0.001). The incidence of other adverse events did not differ significantly between the two groups.

CONCLUSIONS: In patients with coma after out-of-hospital cardiac arrest, targeted hypothermia did not lead to a lower incidence of death by 6 months than targeted normothermia. (Funded by the Swedish Research Council and others; TTM2 ClinicalTrials.gov number, NCT02908308.).

来源:N Engl J Med,查看原文。版权归原作者所有。

参考来源

  1. Dankiewicz J, Cronberg T, Lilja G, et al. Hypothermia versus Normothermia after Out-of-Hospital Cardiac Arrest. N Engl J Med. 2021. PMID: 34133859. doi:10.1056/NEJMoa2100591

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。